Vassilis Chandrinos

Docetaxel Versus Docetaxel Plus Cisplatin As Front-Line Treatment of Patients With Advanced Non—Small-Cell Lung Cancer: A Randomized, Multicenter Phase III Trial

Vassilis Georgoulias, Alexandros Ardavanis, Athina Agelidou et al. · Journal of Clinical Oncology · 2004 · 134 citations · Full text

Docetaxel versus docetaxel plus gemcitabine as front-line treatment of patients with advanced non-small cell lung cancer: A randomized, multicenter phase III trial

Vassilis Georgoulias, Nikolaos Androulakis, Αthanasios Kotsakis et al. · Lung Cancer · 2007 · 46 citations

Oncology, Metronomic Therapy, Docetaxel Versus Docetaxel +10

A multicenter randomized phase II study of the irinotecan/gemcitabine doublet versus irinotecan monotherapy in previously treated patients with extensive stage small-cell lung cancer

Athanasios Pallis, Athina Agelidou, Sofia Agelaki et al. · Lung Cancer · 2008 · 35 citations

Medicine, Metronomic Therapy, Phase Ii Study +6

Pooled Analysis of Elderly Patients with Non-small Cell Lung Cancer Treated with Front Line Docetaxel/Gemcitabine Regimen: The Hellenic Oncology Research Group Experience

Athanasios Pallis, Aris Polyzos, Ioannis Boukovinas et al. · Journal of Thoracic Oncology · 2008 · 30 citations · Full text

Geriatric Oncology, Oncology, Elderly Patients +7

Docetaxel Vs. Vinorelbine in Elderly Patients With Advanced Non–Small-Cell Lung Cancer: A Hellenic Oncology Research Group Randomized Phase III Study

Athanasios Karampeazis, Lambros Vamvakas, Athina Agelidou et al. · Clinical Lung Cancer · 2011 · 24 citations

Geriatric Oncology, Oncology, Elderly Patients +10